Tumor Necrosis Factor-β and Hypercalcemia

References

• Tashjian A. H., Voelkel E. F., Levine L., Goldhaber P. Evidence that the bone resorption-stimulating factors produced by mouse fibrosarcoma cells is prostaglandin E2: a new model for the hypercalcemia of cancer. J. Exp. Med. 1972; 136: 1329–1343
   PubMed Web of Science ®Google Scholar
• Seyberth H. W., Segre G. V., Moegan J. L., Sweetman B. J., Potts J. T., Oates L. A. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N. Engl. J. Med 1975; 293: 1278–1283
   PubMed Web of Science ®Google Scholar
• Franklin R. B., Tashjian A. H. Intravenous infusion of prostaglandin E 2 raises plasma calcium concentration in the rat. Endocrinology 1975; 97: 240–243
   PubMed Web of Science ®Google Scholar
• Mundy G. R., Wilkinson R., Heath D. A. Comparative study of available medical therapy for hypercalcemia of malignancy. Am. J. Med. 1983; 74: 421–432
   PubMed Web of Science ®Google Scholar
• Ibbotson K. J., Twardzik D. R., Souza S. M., Hargreaves W. R., Tadaro G. J., Mundy G. R. Stimulation of bone resorption in vitro by synthetic transforming growth factor-alpha. Science 1985; 228: 1007–1009
   PubMed Web of Science ®Google Scholar
• Ibbotson K. J., Harrod J., Gowen M., Souza S., Smith D. D., Winkler M. E., Derynck R., Mundy R. Human recombinant transforming growth factor a stimulates bone resorption and inhibits formation in vitro. Proc. Nail. Acad. Sci. USA 1986; 83: 2228–2232
   PubMed Web of Science ®Google Scholar
• Tashjian A. H., Voelkel E. F., Lazzaro M., Singer F. R., Roberts A. B., Derynck R., Winkler M. E., Levine L. a and b human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc. Natl. Acad. Sci. USA 1985; 82: 4535–4538
   PubMed Web of Science ®Google Scholar
• Stern P. H., Krieger N. S., Nissenson R. A., Williams R. D., Winkler M. E., Derynck R., Stewler C. J. Human transforming growth factor-alpha stimulates bone resorption in vitro. J. Clin. Invest. 1985; 76: 2016–2019
   PubMed Web of Science ®Google Scholar
• Tashjian A. H., Voelkel E. F., Lloyd W., Derynck R., Winkler M. E., Levine L. Actions of growth factors on plasma-calcium; epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice. J. Clin. Invest. 1986; 78: 1405–1409
   PubMed Web of Science ®Google Scholar
• Mundy G. R. Incidence and pathophysiology of hypercalcemia. Calcif. Tissue Int. 1990; 46: s3–s10
   PubMed Web of Science ®Google Scholar
• Martin T. J., Ebeling P. R. A novel parathyroid hormone-related protein: Role in pathology and physiology. Prog. Clin. Biol. Res. 1990; 332: 1–37
   PubMedGoogle Scholar
• Stewler G. J., Nissenson R. A. Peptide mediator of hypercalcemia in malignancy. Annu. Rev. Med. 1990; 41: 35–44
   PubMed Web of Science ®Google Scholar
• Longo D. L., Broden S. Plasma cell disorders. Principles of Internal Medicine, E. Braunwald. McGraw-Hill Book Co., New York 1989; 1396–1403
   Google Scholar
• Takatsuki K., Uchiyama T., Sagawa K., Yodoi J. Surface markers of malignant lymphoid cells in the classification of lymphoproliferative disorders, with special reference to adult T cell leukemia (Jpn). Jpn. J. Clin. Hematol 1976; 17: 416–421
   PubMedGoogle Scholar
• Uchiyama T., Yodoi J., Sagawa K., Uchino H. Adult T cell leukemia, Clinical and hematological features of 16 cases. Blood 1977; 50: 481–492
   PubMed Web of Science ®Google Scholar
• Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. P., Gallo R. C. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of a patients with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980; 77: 7415–7419
   PubMed Web of Science ®Google Scholar
• Gallo R. C., Kalyanaraman V. S., Sarngadharan M. G., Sliski A., Vonderheid E. C., Maeda M., Nakao Y., Yamada K., Ito Y., Gutensohn N., Murphy S., Bunn P. A., Catovsky D., Greaves M. F., Blayney D. W., Blattner W., Jarrett W. F. H., Hausen H. Z., Seligmann M., Brouet J. C., Haynes B. F., Jegasothy B. V., Jaffe E., Cossman J., Broder S., Fisher R. I., Golde D. W., Robert-Guroff M. Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Research 1983; 43: 3892–3899
   PubMed Web of Science ®Google Scholar
• Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K., Shirakawa S., Miyoshi I. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 1981; 78: 6476–6480
   PubMed Web of Science ®Google Scholar
• Ishibashi K., Hanada S., Hashimoto S. Expression of HTLV-I in serum of HTLV-I-related subjects and the early detection of overt ATL in HTLV-I carriers. J. Immunol. 1987; 139: 1509–1513
   PubMed Web of Science ®Google Scholar
• Ishibashi K., Hanada S., Uozumi K., Otsuka M., Sakurami T., Hashimoto S. An enzyme-linked immunosorbent assay for immune complex of HTLV-I. J. Immunol. Methods 1989; 119: 217–221
   PubMed Web of Science ®Google Scholar
• Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 1982; 79: 2031–2035
   PubMed Web of Science ®Google Scholar
• Seiki M., Hattori S., Hirayama Y., Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA 1983; 80: 3618–3622
   PubMed Web of Science ®Google Scholar
• Hanada S., Uematsu T., Iwahashi M., Nomura K., Utsunomiya A., Kodama M., Ishibashi K., Terada A., Saito T., Makino T., Uozumi K., Kuwazuru Y., Otsuska M., Harada R., Hashimoto S., Sakurami T. The prevalence of Human T-cell leukemia virus type I infection in patients with hematologic and nonhematologic diseases in an adult T-cell leukemia-endemic area of Japan. Cancer 1989; 64: 1290–1295
   PubMed Web of Science ®Google Scholar
• Nomura K., Matsumoto M. Clinical features of adult T-cell leukemia in Kagoshima, the southernmost district in Japan. Acta. Haematol. Jpn. 1981; 44: 1444–1457
   PubMedGoogle Scholar
• Yunoki K., Matsumoto M., Matsumoto T., Kikuchi H., Nomura K., Furusho H., Nishioka K., Hanada S. Adult T-cell leukemia in Kagoshima: Its clinical features and skin lesions. Gann Monograph on Cancer Research 1982; 28: 151–165
   Google Scholar
• Fujihira T., Eto S., Sato K., Oda S., Chiba S., Suzuki H. Evidence of bone resorption-stimuating factor in adult T-cell leukemia. Jpn. J. Clin. Oncol. 1985; 15: 385–391
   PubMed Web of Science ®Google Scholar
• Kodama M. Studies on hypercalcemia associated with adult T-cell leukemia-lymphoma. Igaku Kenkyu (Acta Medica, Jpn) 1987; 57: 317–336
   PubMedGoogle Scholar
• Horton J. E., Raisz L. G., Simmons H. A., Oppenheim J. J., Mergenhagen S. E. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science 1972; 177: 793–795
   PubMed Web of Science ®Google Scholar
• Gowen M., Wood D. D., Thrie E. J., McGuire M. K. B., Russell R. G. G. An interleukin-1 like factor stimulate bone resorption in vitro. Nature 1983; 306: 378–380
   PubMed Web of Science ®Google Scholar
• Stashenko P., Dewhirst F. E., Peros W. J., Kent R. L., Ago J. M. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J. Immunol 1987; 138: 1464–1468
   PubMed Web of Science ®Google Scholar
• Bertolini D. R., Nedwin G. E., Bringman T. S., Smith D. D., Mundy G. R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 1986; 319: 516–518
   PubMed Web of Science ®Google Scholar
• Raisz L. G. Bone resorption in tissue culture: Factors influencing the response to parathyroid hormone. J. Clin. Invest. 1965; 44: 103–116
   PubMed Web of Science ®Google Scholar
• Bataille R., Klein B., Jourdan M., Rossi J. R., Durie B. G. M. Spontaneous secretion of tumor necrosis factor-β by human myeloma cell lines. Cancer 1989; 63: 877–880
   PubMed Web of Science ®Google Scholar
• Garret I. R., Durie B. G. M., Nedwin G. E., Gillespie A., Bringman T., Sabatini M., Bertolini D. R., Mundy G. R. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N. Eng. J. Med. 1987; 317: 526–532
   PubMed Web of Science ®Google Scholar
• Tschachler E., Robert-Guroff M., Gallo R. C., Reitz M. S. Human T-lymphotropic virus-infected T cells constitutively express lymphotoxin in vitro. Blood 1989; 73: 194–201
   PubMed Web of Science ®Google Scholar
• Wano Y., Hattori T., Matsuoka M., Takatsuki K., Chua A. O., Gubler U., Greene W. C. Interleukin 1 gene expression in adult T cell leukemia. J. Clin. Invest. 1987; 80: 911–916
   PubMed Web of Science ®Google Scholar
• Paul N. L., Lenardo M. J., Novak K. D., Sarr T., Tang W., Ruddle N. H. Lymphotoxin activation by human T-cell leukemia virus type I-infected cell lines: Role for NF-kB. J. Virol. 1990; 64: 5412–5419
   PubMed Web of Science ®Google Scholar
• Hanada S., Tsubai F., Namba Y. The characteristics of T-cell lines derived from peripheral blood of patients with adult T-cell leukemia-lymphoma. Recent Advances in RES Research 1987; 25: 124–133
   Google Scholar
• Steffen M., Ottmann O. G., Moore M. A. S. Simultaneous production of tumor necrosis factor-a and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. J. Immunol 1988; 140: 2621–2624
   PubMed Web of Science ®Google Scholar
• Cuturi M. C., Murphy M., Costa-Giomi M. P., Weinmann R., Perussia B., Trincheri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp. Med. 1987; 165: 1581–1594
   PubMed Web of Science ®Google Scholar
• Gray P. W., Aggarwall B. B., Benton V. C., Bringman T. S., Henzel W. J., Jarrett J. A., Leung D. W., Moffat B., Ng P., Svedersky L. P., Palladino M. A., Nedwin G. E. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature 1984; 312: 721–724
   PubMed Web of Science ®Google Scholar
• Pennica D., Nedwin G. E., Hayflick J. S., Seeburg P. H., Derynck R., Palladino M. A., Kohr W. J., Aggarwal B. B., Goeddel D. V. Human necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724–729
   PubMed Web of Science ®Google Scholar
• Wong G. H. W., Goeddel D. V. Tumor necrosis factor a and b inhibit virus replication and synergize with interferons. Nature 1986; 323: 819–822
   PubMed Web of Science ®Google Scholar
• Paya C. V., Kenmotsu N., Schoon R. A., Leibson P. J. Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J. Immunol. 1988; 141: 1989–1995
   PubMed Web of Science ®Google Scholar
• Ming W. J., Bersani L., Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol 1987; 138: 1469–1474
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Broudy V. C., Harlan J. M., Adamson J. W. Tumor necrosis factor a and tumor necrosis factor b stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo. J. Immunol 1988; 141: 3410–3415
   PubMed Web of Science ®Google Scholar
• Ruff M. R., Gilford G. E. Rabbit tumor necrosis factor: Mechanism of action. Infect. Immunol. 1981; 31: 380–385
   PubMed Web of Science ®Google Scholar
• Vilja P., Krohn K., Tuohimaa P. A rapid and sensitive non-competitive avidin-biotin assay for lactoferrin. J. Immunol. Methods 1985; 76: 73–83
   PubMed Web of Science ®Google Scholar
• Goldsmith P. K. A high sensitivity enzyme-linked immunosorbent assay for human immunoglobulin E: comparison of microtiter plate and disk methodologies. Anal. Biochem. 1981; 117: 53–60
   PubMed Web of Science ®Google Scholar
• Kranz B. R., Thiel E., Thiefelder S. Immunocytochemical identification of meningeal leukemia and lymphoma: Poly-L-Lysine-coated slides permit multimarker analysis even with minute cerebrospinal fluid cell specimens. Blood 1989; 73: 1942–1950
   PubMed Web of Science ®Google Scholar
• Huang W. M., Gibson S. J., Facer P., Gu J., Polak J. M. Improved section adhesion for immunocytochemistry using high molecular weight polymers of L-lysine as a slide coating. Histochemistry 1983; 77: 275–279
   PubMedGoogle Scholar
• Miyoshi I., Kubonishi I., Yoshimoto S., Akagi Y., Ohtsuki Y., Shiraishi K., Nagata K., Hinuma Y. Type C virus particles in a cord T-cell line derived by cocultivating normal human cord leukocytes and human leukemic T cells. Nature 1981; 294: 770–771
   PubMed Web of Science ®Google Scholar
• Aggarwall B. B., Moffat B., Harkins R. N. Human lymphotoxin. J. Biol. Chem. 1984; 259: 686–691
   PubMed Web of Science ®Google Scholar
• Ishibashi K., Ishitsuka K., Ueda H., Mishige Y., Yamauchi K., Chuman Y., Shimotokahara S., Nakahara K., Shimoide Y., Uozumi K., Saito T., Makino T., Iwahashi M., Utsunomiya A., Hanada S., Arima T. sIL-2R in patients with ATL or HTLV-I carriers. Igaku to Yakugaku (Jpn) 1990; 24: 1205–1210
   Google Scholar
• Ishibashi K., Shimoide S., Ishitsuka K., Ueda H., Ohno N., Shimotakahara S., Takeshita T., Chuman Y., Nakahara K., Ohtsuska M., Kuwazuru Y., Uozumi K., Saito T., Makino T., Iwahashi M., Utsunomiya A., Hanada S., Arima T. Serum soluble antigen(s) in patients with ATL and its clinical importance in HTLV-I infected populations. Manuscript in preparation
   Google Scholar